CME Prostate carcinoma
Astellas planned to create a certified CME module that would enable urologists to deepen their pathophysiological knowledge of prostate cancer and expand their knowledge of therapy management. For this purpose, Astellas relied on our indication experience and didactic expertise.
We developed the content concept for the CME module on the current therapy landscape for prostate carcinoma, paying special attention to the use of our customer’s innovative drug. We created the text, the scientific infographics and the CME questions – of course all in accordance with the certification guidelines of the medical associations.
After successful certification, the CME module was well received by the target group and made an important contribution to continuous medical education in urology. Astellas was thus able to position itself convincingly as a partner of urologists.